Navigation Links
Newer Blood Tests May Not Improve Heart Risk Assessment
Date:6/30/2009

CRP, other disease-linked factors don't perform better than standard criteria, study finds

TUESDAY, June 30 (HealthDay News) -- Newer biomarkers of cardiac risk, such as inflammation-linked C-reactive protein (CRP), add little or no predictive power to older, established factors such as smoking, obesity, high cholesterol and physical activity, two major studies find.

The newer blood-borne markers have been touted as a better way of assessing heart risk, but recent studies have suggested otherwise.

In fact, the lead author of one of the new studies said his team reported essentially the same finding in an analysis of data from the Framingham Heart Study nearly three years ago.

"A lot of people said [those findings] made sense, but others said the study had limitations -- small numbers, not enough follow-up," said Dr. Thomas Wang, associate director of the Heart Failure Service at Massachusetts General Hospital in Boston.

So, he collaborated with Swedish researchers in a study with larger numbers -- more than 5,000 participants -- who were followed for a longer time, an average of 12.8 years. They looked at more offbeat biomarkers and used newer statistical methods for evaluating risk.

"The long and short of it was that we had the same conclusion -- that these biomarkers add a little bit but not a lot," Wang said. "There is not enough evidence to recommend that any of these biomarkers be routinely measured."

The six biomarkers surveyed in the study were CRP, an indicator of inflammation; cystatin C; lipoprotein-associated phospholipase 2; midregional proadrenomedullin; midregional proatrial natriuretic peptide; and N-terminal pro-B type natriuretic peptide.

Five of the biomarkers did help predict future heart problems, and three predicted problems in models that adjusted for conventional risk factors, but the improvement over usual risk factor assessments was "minimal" and "did not reclassify a substantial proportion of individuals to higher or lower risk categories," said the report, published July 1 in the Journal of the American Medical Association.

A second study in the same issue of the journal, done by British researchers at Imperial College London, looked only at CRP. That study, involving almost 130,000 people, examined genes that control blood levels of the inflammation-related molecule. The study found no association between genetically controlled levels of CRP and heart disease.

"This study suggests that development of therapeutic strategies targeting specific reductions in plasma levels of CRP are unlikely to be fruitful," the researchers concluded.

The new studies do not say that CRP is of no use in assessing heart risk, noted Dr. James A. de Lemos, an associate professor of medicine at the University of Texas Southwestern Medical Center in Dallas and co-author of an accompanying editorial.

"This study shows a modest incremental value," de Lemos said. "Other studies focusing on more homogeneous populations, such as the elderly, clearly show value."

But in general, the predictive value of the newer biomarkers is limited, he said. "In these low-risk populations, there is no 'wow' marker, no major breakthrough in terms of markers that allow us to assess risk in a generally healthy population," de Lemos said.

De Lemos does test for biomarkers in his clinical practice: "Selectively, and not across the board," he said. "I do it on an individual basis. For example, if I am on the fence about whether to use a statin [a cholesterol-lowering drug], I may measure CRP levels. It is an occasional test for me."

Despite the limited usefulness of alternate biomarkers found in these studies, "research should continue to go on in these areas, without a doubt," de Lemos said.

Wang agreed. He said it's still possible that newer biomarkers of potentially greater predictive value will be identified in the years ahead, and they should be tested.

"But the basic risk factors do pretty well, and we don't pay as much attention to these basic risk factors as we should," Wang said.

More information

The American Heart Association has more on heart disease risk factors.



SOURCES: Thomas Wang, M.D., associate director, Heart Failure Service, Massachusetts General Hospital, Boston; James A. de Lemos, M.D., associate professor, medicine, University of Texas Southwestern Medical Center, Dallas; July 1, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Panel OKs Newer Antipsychotics for Children
2. FDA Panel Mulls Newer Antipsychotics for Kids
3. Newer Antipsychotics May Boost Weight in Alzheimers Patients
4. Newer Sedative May Reduce Delirium in ICU Patients
5. Zoloft, Lexapro the Best of Newer Antidepressants
6. Newer Contraceptives Dont Increase Heart Risk
7. Newer Antipsychotics Pose Cardiac Risk: Study
8. Most Newer Antipsychotics No Better Than Older Ones, Just Different
9. Newer antipsychotics no better than older drug in treating child and adolescent schizophrenia
10. First generation antipsychotic drugs as effective as newer ones in some children
11. Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Newer Blood Tests May Not Improve Heart Risk Assessment
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 ... bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for people ... such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage ... up its marketing efforts with its product now available through Jet.com. , After ... public. The effervescent powdered drink is designed to quickly detox the body thereby avoiding ...
(Date:8/18/2017)... ... 2017 , ... 800response, the leading provider of dynamic call-to-action ... launch of a redesigned corporate website, 800response.com . , Key features ... an enhanced search directory for businesses and advertising agencies to use to ...
(Date:8/18/2017)... ... ... “Dangerous Inheritance”: a mystery about saving the family farm. “Dangerous Inheritance” ... where she was raised on a farm. As Diane wrote this story, she ... friendships and mantra of ‘neighbors helping neighbors’ have always been a large part of ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Beyond Our Imaginations: The Infinite God”: shows the ... Infinite God” is the creation of published author, Mark Lawrence, born in Michigan, the ... “The problem with becoming a greater man of God is that I have to ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... known U.S. mesh product liability claims and that it ... U.S. claims at reasonable values. Under the agreements, Endo ... of 2017 and continuing through the fourth quarter of ... the Company intends to increase its mesh product liability ...
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and ... driving up healthcare costs and threatening outcomes, were problems ... supply and IVD industry that support them, met this ... market researcher said that drugs of abuse, procalcitonin and ... sessions at the organization,s 69th meeting in ...
(Date:8/2/2017)... Aug. 2, 2017  Life Flight Network and PeaceHealth Oregon ... improves patient care and operational efficiency for patients at hospitals ... , Cottage Grove , and ... PeaceHealth and Life Flight Network work collaboratively to move patients ... or when a time sensitive emergency exists. ...
Breaking Medicine Technology: